Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03126565 · ClinicalTrials.gov registry record · NA
Evaluation of the Philips Lifeline CareSage Risk Assessment System
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 370
- Enrollment target
NCT03126565: Completed NA study, sponsored by Massachusetts General Hospital.
NCT03126565 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 370 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03126565, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 370 participants
- Enrollment target
Study Summary
This study is being done to evaluate the impact of a system called CareSage. The CareSage system is a technology that uses clinical data to monitor, identify and target care to patients at risk of being transported to the hospital. The investigators want to see whether the CareSage system is effective in helping to identify hospital admissions which can be prevented.
Interventions
- OTHER Lifeline CareSage Flagging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2017-05-19 |
| Est. Completion | 2019-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03126565
The ClinicalTrials.gov registry entry for NCT03126565 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 370 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lifeline CareSage Flagging is the first listed.
NCT03126565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03126565 about?
NCT03126565 is a clinical study titled "Evaluation of the Philips Lifeline CareSage Risk Assessment System". This study is being done to evaluate the impact of a system called CareSage. The CareSage system is a technology that uses clinical data to monitor, identify and target care to patients at risk of being transported to the hospital. The investigators want to see whether the CareSage system is effecti...
What is the current status of trial NCT03126565?
This trial is currently completed. It is a NA study. The enrollment target is 370 participants. The study started on 2017-05-19. Estimated completion is 2019-11-30.
What interventions are being tested in trial NCT03126565?
The interventions under investigation include: Lifeline CareSage Flagging (OTHER).
Who is sponsoring clinical trial NCT03126565?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.